India /
Published 18.11.20
India's hopes hinge on vaccines on trial at home
...
By G.S. Mudur
in New Delhi
Business /
Published 05.03.20
Nod for Zydus liver drug
Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, known as...
By Vivek Nair
in Ahmedabad
Business /
Published 24.10.18
Zydus and parent Cadila bag Complan
Zydus Wellness and its parent Cadila Healthcare will jointly buy Heinz India in a deal worth Rs 4,595 crore.The two companies have signed definitive agreements to buy Heinz India, a subsidiary of Kraf...
By Our Special Correspondent
in Mumbai
Business /
Published 24.10.18
Heinz India to be sold for Rs 4,595cr
Cadila Healthcare along with Zydus Wellness will acquire Heinz India in a deal worth Rs 4,595 crore, a regulatory filing by the company said on Wednesday. The two companies have signed definitive agr...
By PTI
in New Delhi
Advertisement
Download our latest App
to get update on the go...
Advertisement
Advertisement
